Medical Propellant

Honeywell Solstice® Air medical propellant is a breakthrough in near-zero global warming potential (GWP) technology for pressurized metered dose inhalers. 

Featured Applications

Metered Dose Inhalers 

Honeywell provides a Near-Zero Global Warming Potential (GWP) aerosol propellant for Metered Dose Inhalers (MDI).

  • Solstice® Air: Solstice Air is a breakthrough for pressurized metered dose inhalers (pMDIs). A non-flammable and low global warming potential (GWP) alternative to hydrofluorocarbons, it is non-ozone-depleting, VOC-exempt (U.S. EPA and CARB), with an ultra-low GWP of less than 1.

Enabling better business outcomes 

Honeywell Teams With AstraZeneca To Develop Next-Generation Respiratory Inhalers That Use Near-Zero Global Warming Potential Propellant

Honeywell today announced a commercial partnership with AstraZeneca to develop and bring to market next-generation respiratory inhalers that use near-zero global warming potential (GWP) propellants to treat asthma and chronic obstructive pulmonary disease (COPD).

Medical Propellant
Medical Propellant

Medical Propellant

A Near-Zero Global Warming Potential Propellant for Metered Dose Inhalers

Samples of Solstice Air are available for testing. To request a sample, please complete our contact us form.

Refine By
Clear
ASHRAE Safety Classification
Application

Product Finder

Start your search with category name, product name, part number, etc.